Q3 Colocation Revenue Jumps ~60% Sequentially to $215.4M, Adjusted EBITDA More Than Triples
CORZ is trading near its 52-week low of $12.31 (9.8% above the low) on elevated volume (1.9× avg).
Summary
Core Scientific's Q3 2026 revenue was $232.9M and EPS was 47c, with colocation revenue rising nearly 60% sequentially to $215.4M and Adjusted EBITDA more than tripling, per the 8-K filed today. That confirms the AI/HPC hosting pivot disclosed in the July 10-Q is converting into revenue fast, and it lands a day after the stock fell 9.6% to $12.88 on election-driven data-center policy worries. The headline release itself carries no figures, so the numbers come from the filing.
At the time of this announcement, CORZ was trading at $13.52 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $12.31 to $30.46. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.